Short answer
Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Consent fee doubled to $5.00 per $1,000 of notes, from $2.50, increasing the issuer’s cost to secure approval.
Surgery Partners, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Consent fee doubled to $5.00 per $1,000 of notes, from $2.50, increasing the issuer’s cost to secure approval
- Solicitation covers $1.225B of 7.250% senior notes due 2032, creating a potentially material transaction expense
- Consent deadline: 5:00 p.m. New York time on November 20, 2026, unless extended or terminated
- Proposed amendments would preserve permitted-holder status for BSMH and affiliates after the merger
- Without operative amendments, the merger would trigger a Change of Control under the notes indenture, potentially affecting refinancing or repayment obligations
Item EX-99.1 · Exhibit EX-99.1
- Consent fee doubled to $5.00 per $1,000 from $2.50 for timely, non-revoked consents
- Applies to $1,225,000,000 of 7.250% senior notes due 2032
- Majority approval required, with expiration scheduled November 20, 2026 at 5:00 p.m. New York time
- Previously submitted consents remain eligible, reducing friction for reaching the required threshold
- Proposed amendments relate to Surgery Partners’ pending acquisition by an affiliate of Bon Secours Mercy Health
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Surgery Partners, Inc. 8-K filings
Get the next SGRY 8-K as it lands
Follow SGRY for push alerts, or ask the research agent what this filing means.